Adam Hloska

  • Citations Per Year
Learn More
PURPOSE This study was aimed at evaluating the extent of non-persistence with statin therapy in elderly patients after an ischemic stroke and identifying patient-related characteristics that are risk factors for non-persistence. METHODS The evaluable study cohort (n = 2748) was derived from the database of the largest health insurance provider in the(More)
OBJECTIVES This study investigated the extent of, and patient-related characteristics for, non-persistence with antiplatelet therapy during follow-up in elderly patients after their first ischaemic non-cardioembolic stroke. METHODS A database of the largest health insurance provider in the Slovak Republic was used to assemble the study cohort of 4319(More)
OBJECTIVES The aim of our study was to describe approaches to health technology assessment (HTA) for medicines in the Slovak healthcare system and the related decision-making processes concerning reimbursement for medicines. METHODS Analysis of the Slovak legislative framework related to HTA and the reimbursement process for medicines was performed.(More)
BACKGROUND Antiplatelet therapy following a transient ischemic attack (TIA) constitutes an important secondary prevention measure. AIMS The study was aimed at evaluating the development of non-persistence with antiplatelet therapy in elderly patients after a TIA and identifying patient-related characteristics associated with the probability of(More)
  • 1